Viscosupplementation System Market Growth, Size, Share, Industry Report and Forecast 2021-2027

The global viscosupplementation market is anticipated to grow at a CAGR of around 8.6% during the forecast period (2021-2027). The key factors that driving market growth include the increasing prevalence of osteoarthritis across the globe coupled with the rising demand for viscosupplementation. For instance, according to Centre for Disease Control and Prevention estimation of 1 in 4 (or 54.4 million), Although there are more than 100 types of arthritis, osteoarthritis (OA) is the most common, affecting 32.5 million adults in the US. Adults in the US suffer from arthritis, with the number expected to rise to 78 million by 2040. Further, improvement in healthcare infrastructure and providence of medical assistance also drive the market. For instance, according to Commonwealth Fund, in 2018, almost 92% of the population got medical insurance coverage in the US and almost 55% population was covered under Employer-sponsored health insurance.

To Request a Sample of our Report on Viscosupplementation System Market:  https://www.omrglobal.com/request-sample/viscosupplementation-market

Moreover, significant advancement in the viscosupplementation by the major players in the market also propel the growth of the market. For instance, in January 2019, OrthogenRx introduced TriVisc, a sodium hyaluronate for the treatment of knee osteoarthritis in a three-injection regimen in the US. TriVisc is the least expensive in terms of price and this launch will be allowing OrthogenRx to stay the course in providing healthcare practitioners and patients with reasonable and reliable pricing for all goods.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027

Segment Covered- 

  • By Product
  • By Application

Regions Covered-

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
  • Competitive Landscape- Anika Therapeutics, Inc., LG chem., Smith & Nephew Plc, Seikagaku Corp., Lifecore Biomedical, LLC, Sanofi S.A., Zimmer Biomet Holdings, Inc., and others

 (Get 15% Discount on Buying this Report)

A full Report of Viscosupplementation System Market is Available at:  https://www.omrglobal.com/industry-reports/viscosupplementation-market

Global Viscosupplementation Market Report Segment

By Product

  • Single-Injection
  • Three-Injection
  • Five-Injection

By Application

  • Knee
  • Hip
  • Ankle
  • Others

(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)

 

Leave a Reply

Your email address will not be published. Required fields are marked *